Opinion: Reducing Foodborne Illness

New testing technologies and improved communication among regulatory agencies are making strides in the fight against foodborne disease.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA COMMONS, IVAN ATMANAGARA

As evidenced by the E. coli outbreak in Europe earlier this year, which claimed dozens of lives and sickened thousands more, bacterial contamination of foods remains a significant problem. This outbreak clearly demonstrated that, despite recent improvements in technologies to detect and trace foodborne outbreaks, it will take continual advances in knowledge and techniques to prevent future epidemics.

Each year, roughly one out of six Americans, or 48 million people, contract foodborne illnesses, according to estimates from the United States Centers for Disease Control and Prevention (CDC). The economic impact of foodborne illness is staggering, with a recent report from the University of Florida’s Emerging Pathogens Institute concluding that five leading pathogens —Campylobacter, Salmonella, Listeria monocytogenes, Toxoplasma gondii and norovirus — cost the nation $12.7 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • J. Stan Bailey

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide